Nidan Laboratories And Healthcare Ltd

NSE: NIDAN · Healthcare · 11 announcements

Share price: ₹13.00
Market cap: ₹18.07 Cr
Revenue (annual): ₹25.54 Cr
Net profit (annual): ₹1.51 Cr
P/E (TTM): 12.0×Sector 53.1×
Promoter holding: 57.04%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 3 Financial Results 2 Annual General Meeting 2 Management Change 1 Legal & Regulatory 1 Board Meeting Outcome 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

25 May 2026 17:43 IST NSE

Financial Results

Nidan Laboratories And Healthcare H2 FY26 Results: Net Profit ₹0.1 Cr, Down 88.9% YoY

Nidan Laboratories And Healthcare Ltd reported revenue from operations of ₹12.4 Cr (-11.4% YoY) and net profit of ₹0.1 Cr (-88.9% YoY) for H2 FY26.

Key figure: Net profit ₹0.1 Cr · -88.9% YoY

Open full results → Read the filing ↗

25 May 2026 17:42 IST NSE

Financial Results

Nidan Laboratories And Healthcare Financial Results

Nidan Laboratories reported total income of ₹27.40 Crore for FY26. The board also approved the re-appointment of two independent directors and its statutory auditors.

Value: ₹27.40 Cr

Read the filing ↗